The new study published online Monday by the Journal of the American Medical Association, and the sooner one, published last month by the brand new England Journal of Medication, were funded by the FDA and various other U.S. Organizations to obtain a clearer picture of the risk linked to the medicines following the 2006 advisory panel hearings. Related StoriesCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyGood sleep patterns are good for your heartStudy links antibiotic use during childhood to pounds gainThe study in JAMA compared about 150,359 adult users of ADHD medications between 25 and 64 years old to almost 300,000 nonusers.Founded in 1987, AMS Biotechnology is recognized today as a respected company adding to the acceleration of discovery through the provision of cutting-edge life research technology services and products for research and advancement in the medical, nourishment, cosmetics and energy industries. The AMSBIO range contains expert antibodies, peptides and recombinant proteins. Furthermore the company will be able to draw upon in-depth knowledge in extracellular matrices to provide elegant solutions for learning cell motility, migration, proliferation and invasion.